Lincoln Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on August 04, 2015 to consider and approve the quarterly un-audited financial results for the aforesaid quarter.In view of above, the trading window will remain close from the date of this letter and shall reopen after the expiry of 48 hours from the time of publication of the results.
The above information is a part of company’s filings submitted to BSE.